Arm Holdings plc - American Depositary Shares (ARM)
268.93
+1.08 (0.40%)
NASDAQ· Last Trade: Aug 11th, 5:03 PM EDT
Detailed Quote
Previous Close
267.85
Open
273.10
Bid
268.50
Ask
269.40
Day's Range
265.37 - 273.39
52 Week Range
100.02 - 452.70
Volume
3,169,488
Market Cap
-
PE Ratio (TTM)
358.57
EPS (TTM)
0.8
Dividend & Yield
N/A (N/A)
1 Month Average Volume
6,147,313
Chart
About Arm Holdings plc - American Depositary Shares (ARM)
Arm Holdings plc is a leading technology company that specializes in semiconductor and software design, primarily focusing on microprocessor and system-on-chip (SoC) architectures. Its innovative designs are integral to a wide range of applications, from mobile devices to embedded systems and Internet of Things (IoT) products. Arm's technology enables low power consumption and efficient performance, making it a popular choice among manufacturers and developers in the electronics industry. The company collaborates closely with partners to drive the advancement of next-generation computing and connectivity solutions, playing a crucial role in shaping the future of digital devices and applications. Read More
The Alaska Wildlife Conservation Center is a popular destination for travelers who want to experience Alaska’s wildlife and natural beauty. Located near th
NEW YORK, NY - August 10, 2026 - Yifeng Zhang, principal of the Yifeng Zhang Family Office, has structured the firm’s acquisition platform around long-term real estate categories including raw land, Section 8 affordable housing and international land investments. The New York-based family office operates as a private, principal-led investment platform, with Yifeng Zhang Princem serving as its operational arm for acquisition execution, development partnerships and hospitality collaborations.
SOLE Fitness announced the launch of the CC81 Cardio Climber - a hybrid stepper-climber machine offering high-intensity, full-body cardio with low joint impact.
Bringing a newborn home for the first time is more of joy and also a quiet panic moment too. You've read the books, attended the classes, and packed the ho
SPONSORED CONTENT -- (StatePoint) As you age, there’s a pretty good chance you’ll eventually develop high blood pressure, also known as hypertension. In fact, according to one study, about 60% of people get hypertension by the time they reach age 60.
For the past decade, the global artificial intelligence boom was built on digital abundance. Massive text corpora, billions of indexed web pages, high-reso
As is so often the case, the market's come to a long-term conclusion based on short-term noise. That spells opportunity for forward-thinking investors.
HONG KONG, [08/08/2026] —Naslab launches Ncore 3.0, an upgraded automated trading system with enhanced execution logic and risk-aware filtering, designed to support structured decision-making across digital asset markets.
Big celebrations demand a massive upgrade in your social life. If you have a huge birthday coming up or a corporate celebration, showing up alone is a terr
A five-star hotel by itself doesn't make a trip memorable anymore, not for people who've already stayed there. What tends to stick is something smaller and
Twenty-four immigration providers operating in Tbilisi were assessed for the 2026 Best Immigration Lawyers in Tbilisi ranking published by TbilisiExperts.ge, measured on published fee transparency, verifiable company identity, whether the provider represents clients in administrative appeals, and whether an enquiry written in English reaches a person rather than a form.
BIRMINGHAM, Ala. - Cory Watson Attorneys is proud to welcome Chrissy Tubbs as the newest associate attorney to the firm's growing legal team. Tubbs joins the firm with a passion for advocating on behalf of individuals and families whose lives have been impacted by serious injuries and catastrophic events, bringing both compassion and determination to every client she serves.
The HEAL and RISE initiative expands into a tri-country movement supporting youth and women's mental health through expanded awareness, advocacy, and community programs across three nations, by Beyond The Call 24/7.
Ocugen (NASDAQ:OCGN) said its second quarter marked progress across its late-stage ophthalmology pipeline, including FDA clearance to begin a Phase III study of OCU410 in geographic atrophy and an RMAT designation for the program.
Chairman, Chief Executive Officer and Co-Founder Shankar Musunuri sa
